Leadership of Rutgers Cancer Institute of New Jersey

Steven K. Libutti, MD, FACS Director, Vice Chancellor for Cancer Programs, Rutgers Biomedical and Health Sciences, and Senior Vice President of Oncology Services, RWJBarnabas Health
Joseph Aisner, MD Interim Associate Director for Clinical Science	David A. August, MD Interim Chief, Surgical Oncology
Kevin Coyle Chief Financial Officer	Shabbar Danish, MD Chief, Neurosurgical Oncology
Richard Drachtman, MD Interim Chief, Pediatric Hematology/Oncology	David J. Foran, PhD Chief Informatics Officer and Executive Director of Biomedical Informatics
Shridar Ganesan, MD, PhD Associate Director for Translational Science and Chief, Molecular Oncology	Susan Goodin, PharmD Executive Director, Statewide Affairs
Bruce G. Haffty, MD, MS Chief of Staff and Chair, Radiation Oncology	Isaac Kim, MD, PhD Chief, Urologic Oncology
Edmund C. Lattime, PhD Associate Director for Research and Education Affairs	Sharon Manne, PhD Associate Director for Cancer Prevention, Control and Population Science
Janice Mehnert, MD Director, Phase I/Investigational Therapeutics	Lorna Rodriguez, MD, PhD Director, Precision Medicine and Interim Chief, Gynecologic Oncology
Roger Strair, MD, PhD Chief, Hematologic Malignancies and Blood and Marrow Transplantation	Antoinette M. Stroup, PhD Director, New Jersey State Cancer Registry and Principal Investigator, NCI-SEER Registry
Linda Tanzer Chief Administrative and Operating Officer and Associate Director for Administration and Planning	Deborah L. Toppmeyer, MD Chief Medical Officer and Chief, Solid Tumor Oncology
Eileen White, PhD Deputy Director, Chief Scientific Officer and Associate Director for Basic Science	Steven Zheng, PhD Division Chief of Cancer Pharmacology

TRAFFIC ALERT
effective 3/6/17

Proud member of